Fit For ATMPs? Creating an EU Regulatory Framework that Works for Transformative Therapies

Hosted by the MEP Interest Group for Transformative Therapies (TRANSFORM)

15:00 - 17:00

This meeting will bring together policy-makers (MEPs, representatives of EU institutions, national representatives), regulators (EMA), patient representatives, medical experts, scientists, researchers, industry representatives and academics to discuss recommended changes in policy and practice, and offer solutions to ensure a regulatory framework that is fit-for purpose for ATMPs and has patient safety at its centre.

The discussion will focus on legislative dossiers that touch on the ATMP regulatory framework, namely the review of the Blood, Tissues and Cells legislation (expected mid-July) and the General Pharmaceutical legislation.

A recording will be made available after the event.

Confirmed Speakers

@TRANSFORM_CGT on Twitter Follow us →

RT @CancerPatientsE: 📣 We are calling for better use of real-world evidence to improve health outcomes! Join us and sign the Call to Action…
23 March at 4:09pm
RT @RWE4Decisions: Dr A Natz @EUCOPE shares the value of the multi-stakeholder collaboration in #RWE4Decisions and @TRANSFORM_CGT, key init…
23 March at 4:08pm
Today @ 🇪🇺 #HealthTechSummit, Dr.Natz @Eucope mentioned @TRANSFORM_CGT as a multi stakeholder platform fostering dialogue & providing recommendations on how to make the best possible use of #RWD to enable patient access to therapies ➡️see Charter Rec#3: https://t.co/XAeoSimAzh.
23 March at 4:08pm